Lifegraph

Company Overview

Snapshot

Founded in June 2014 by Keren Sela, Prof. Uri Nevo, and Asaf Liberman, Lifegraph operated with 1–10 employees. The company secured funding in one round from Sanara Ventures. In January 2019, Lifegraph received funding from Sanara Ventures.

Business overview

Lifegraph develops AI technology for migraine management, leveraging machine learning and smartphone data to predict symptom onset for chronic conditions. The company's clinically tested technology creates personal patterns based on smartphone activity, tracking metrics like sleep, activity, and weather to forecast migraines. This enables timely interventions through medication or lifestyle changes, aiming to reduce attack intensity and duration. Lifegraph serves individuals managing migraines, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring.

Strategic signal

Lifegraph ceased operations in November 2019, indicating a significant shift in its business trajectory. This event signals to investors and innovation teams that the company is no longer active in the market, concluding its efforts in AI-driven migraine management.

Company Intelligence Q&A

What is Lifegraph's primary focus?

Lifegraph primarily focuses on developing AI technology for migraine management, using machine learning and smartphone data to predict symptom onset.

When was Lifegraph founded?

Lifegraph was founded in June 2014.

Who are the founders of Lifegraph?

The co-founders of Lifegraph are Keren Sela, Prof. Uri Nevo, and Asaf Liberman.

What was the operational status of Lifegraph as of November 2019?

Lifegraph ceased to operate in November 2019.